Onconova Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel products to treat cancer. The company has proprietary targeted anti-cancer agents designed to disrupt specific cellular pathways that are important for cancer cell proliferation. Onconova's novel, pr... Onconova Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel products to treat cancer. The company has proprietary targeted anti-cancer agents designed to disrupt specific cellular pathways that are important for cancer cell proliferation. Onconova's novel, proprietary multi-kinase inhibitor ON 123300 is currently in a dose-escalation and expansion Phase 1 trial in China, and an IND has been filed in the U.S. Its product candidate oral rigosertib is currently in a dose-escalation and expansion Phase 1 investigator-initiated study targeting patients with KRAS+ lung adenocarcinoma in combination with nivolumab. 詳細を表示
Expert Systems and Traws Pharma Report Breakthrough in H5N1Bird Flu Antiviral Program PR Newswire SAN DIEGO, Jan. 10, 2025 SAN DIEGO, Jan. 10, 2025 /PRNewswire/ -- Expert Systems, a hybrid AI...
Traws Pharma, Inc. Announces Financing up to $72.6 Million from Leading Healthcare Institutional Investors to Advance Tivoxavir Marboxil Development for H5N1 Bird Flu to Approval PR...
Traws Pharma Announces Progress in Developing Tivoxavir Marboxil for H5N1 Bird Flu PR Newswire NEWTOWN, Pa., Dec. 23, 2024 Investigational agent in development for treatment or prevention of H5N1...
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 3.66 | 42.4593967517 | 8.62 | 12.76 | 8.06 | 148731 | 8.78988145 | CS |
4 | 7.39 | 151.124744376 | 4.89 | 19.44 | 4.619 | 1886240 | 12.24306674 | CS |
12 | 7.6 | 162.393162393 | 4.68 | 19.44 | 4.06 | 568403 | 12.16806166 | CS |
26 | 3.605 | 41.5561959654 | 8.675 | 19.44 | 4.06 | 298340 | 11.6269141 | CS |
52 | -12.47 | -50.3838383838 | 24.75 | 24.75 | 4.06 | 234916 | 12.34809927 | CS |
156 | -12.47 | -50.3838383838 | 24.75 | 24.75 | 4.06 | 234916 | 12.34809927 | CS |
260 | -12.47 | -50.3838383838 | 24.75 | 24.75 | 4.06 | 234916 | 12.34809927 | CS |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約